Press release
Idiopathic Hypersomnia Treatment Market (2026) | Idiopathic Hypersomnia Therapies, Wakefulness Agents, CNS Drugs, Sleep Disorder Therapies & Gloabl Growth | Top Companies 2026 - Jazz Pharmaceuticals, Harmony Biosciences, Eisai, Shionogi
Idiopathic Hypersomnia Treatment Market Size 2026
Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/idiopathic-hypersomnia-treatment-market?kb
United States: Recent Industry Developments (Idiopathic Hypersomnia Treatment Market)
✅ March 2026: Eli Lilly expanded its neuroscience portfolio through the acquisition of Centessa Pharmaceuticals, strengthening its pipeline in orexin receptor-based therapies targeting idiopathic hypersomnia and narcolepsy.
✅ February 2026: Alkermes advanced integration of Avadel Pharmaceuticals' sleep medicine assets following its strategic acquisition, reinforcing presence in sodium oxybate-based IH treatment therapies.
✅ January 2026: Jazz Pharmaceuticals enhanced clinical development programs for Xywav, focusing on real-world evidence expansion and optimized dosing strategies for idiopathic hypersomnia patients.
✅ December 2025: Harmony Biosciences accelerated late-stage evaluation of wake-promoting therapies, strengthening its position in histamine-based mechanisms for excessive daytime sleepiness disorders.
Ready to scale in the Idiopathic Hypersomnia Treatment Market? Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/idiopathic-hypersomnia-treatment-market?kb
List of Key Players 2026:
Jazz Pharmaceuticals plc, Harmony Biosciences Holdings, Inc., AVADEL PHARMACEUTICALS PLC, Zevra Therapeutics, Inc., Teva Pharmaceuticals USA, Inc., Mylan N.V., Hoffmann-La Roche Limited, BIOPROJET, Theranexus, Shionogi Inc.
Growth Forecast Projected 2026:
The Global Idiopathic Hypersomnia Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Key Developments 2025-2026:
✅ February 2026: Pharmaceutical companies advanced development of next-generation wakefulness-promoting agents aimed at improving daytime alertness and reducing excessive sleep duration in idiopathic hypersomnia patients.
✅ January 2026: Clinical research activity expanded, with increased focus on improving long-term safety profiles and efficacy of CNS stimulants and orexin-based therapeutic candidates.
✅ December 2025: Healthcare providers reported improved diagnosis rates due to enhanced sleep disorder screening protocols and wider adoption of polysomnography and sleep latency testing.
✅ November 2025: Biopharmaceutical firms strengthened pipelines by investing in novel neuromodulatory and targeted CNS therapies addressing hypersomnia-related neurochemical imbalance.
✅ October 2025: Digital health platforms and sleep-tracking technologies were increasingly integrated into patient management, enabling better symptom monitoring and treatment optimization.
How Our Market Research Process Works:
The global Idiopathic Hypersomnia Treatment Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Idiopathic Hypersomnia Treatment ecosystem.
Recent Mergers & Acquisitions (M & A) 2025-2026:
• Eli Lilly acquired Centessa Pharmaceuticals for up to $7.8B (2026), expanding its orexin receptor 2 agonist pipeline including cleminorexton targeting idiopathic hypersomnia and narcolepsy
• Eli Lilly completed a $6.3B upfront acquisition of Centessa Pharmaceuticals, strengthening its sleep-wake disorder portfolio including Phase 2 IH candidate cleminorexton
• Alkermes completed acquisition of Avadel Pharmaceuticals ($2.3B deal closed in Q1 2026), entering the sleep medicine market alongside ongoing IH-related development programs
• Alkermes acquisition of Avadel strengthens
commercialization of sleep disorder therapies, supporting expansion into idiopathic hypersomnia treatment ecosystem via orexin pathway R&D
Request Strategic Market Customization: https://datamintelligence.com/customize/idiopathic-hypersomnia-treatment-market?kb
Japan: Recent Industry Developments (Idiopathic Hypersomnia Treatment Market)
✅ March 2026: Takeda Pharmaceutical advanced CNS-focused research collaborations exploring next-generation orexin pathway modulators for sleep-wake regulation disorders, including idiopathic hypersomnia.
✅ February 2026: Otsuka Pharmaceutical expanded neuroscience pipeline development activities targeting rare sleep disorders with improved CNS stimulant and wake-promoting mechanisms.
✅ January 2026: Eisai strengthened global neuroscience partnerships focusing on digital sleep disorder diagnostics and adjunctive therapies for hypersomnia management.
✅ December 2025: Shionogi expanded early-stage research initiatives into neuro-regulatory compounds aimed at improving sleep architecture and daytime alertness disorders.
Major Focused Key Segmentations 2026:
By Treatment Type: Non-Stimulant Wake-Promoting Medications (Modafinil, Armodafinil, Solriamfetol, Pitolisant and Others), CNS Depressants(Xyrem , Xywav), Psychostimulants(Amphetamines, Methylphenidate, Others) and Others
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Growth Analysis for Market:
⇥ North America: Leading region driven by high diagnosis rates, advanced sleep disorder treatment infrastructure, and strong adoption of wakefulness-promoting therapies.
⇥ Asia-Pacific (including Japan): Japan shows strong clinical adoption supported by advanced neurology care, while China, India, and Southeast Asia are expanding diagnosis and treatment awareness for sleep disorders.
⇥ Europe: Growth supported by rising awareness of rare sleep disorders, improving access to sleep clinics, and increasing neurological research initiatives.
⇥ Middle East & Africa: Emerging market with gradual improvements in sleep disorder diagnosis and expanding healthcare infrastructure across key urban centers.
We Provide Benefits of the Report:
Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.
Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.
Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.
Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.
Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.
Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.
Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.
Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.
Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.
Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=idiopathic-hypersomnia-treatment-market?kb
FAQ
Q: How rapidly will the Market expanding?
A: The Idiopathic Hypersomnia Treatment market is projected to grow at a high CAGR between 2023 and 2030.
Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Idiopathic Hypersomnia Treatment Market (2026) | Idiopathic Hypersomnia Therapies, Wakefulness Agents, CNS Drugs, Sleep Disorder Therapies & Gloabl Growth | Top Companies 2026 - Jazz Pharmaceuticals, Harmony Biosciences, Eisai, Shionogi here
News-ID: 4467878 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Future of Solar PV Panels Market (2026-2033) | Supported by Strong Asia-Pacific …
DataM Intelligence has unveiled its latest report on the "Solar PV Panels Market Size 2026" delivering powerful insights into key trends, future growth opportunities, and evolving market challenges. Designed to empower smarter decision-making, the report equips businesses with the strategic intelligence needed to stay ahead in a competitive landscape. By blending robust qualitative analysis with data-driven quantitative research, DataM Intelligence offers a well-rounded perspective that helps organizations decode complex market…
Buy Now Pay Later (BNPL) Market to Reach USD 238.56 Billion by 2033 at 21.04% CA …
The global buy now pay later (BNPL) market reached USD 51.6 billion in 2025 and is expected to reach USD 238.56 billion by 2033, growing at a CAGR of 21.04% during the forecast period of 2026 to 2033. The market is witnessing rapid growth driven by the increasing preference for flexible and interest-free payment options among consumers.
The rising adoption of digital payment solutions, growing e-commerce penetration, and increasing consumer demand…
Holter Analysis System & Software Market (2026) | ECG Monitoring, Arrhythmia Scr …
DataM Intelligence has released a new research report titled "Holter Analysis System & Software Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market…
Enterprise Asset Management Market to grow at over 10% CAGR | Top Companies 2026 …
The enterprise asset management (EAM) market is expected to grow at a CAGR of over 10% during the forecast period 2026-2033.
Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/enterprise-asset-management-market?prasad
DataM Intelligence unveils exclusive insights into the Enterprise Asset Management Market 2026, highlighting emerging trends, growth drivers, and key regional opportunities worldwide. The report helps solve critical business challenges by identifying high-growth segments and reducing investment risks through actionable forecasts.…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
